drugset / Trial / NCT01477073

Multiple Dose FSH-GEX(TM) in Healthy Volunteers

NCT01477073 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of the current study is the pharmacokinetic and pharmacodynamic characterization of a multiple dose administration of FSH-GEX™ in healthy pituitary-suppressed female volunteers, in comparison with two marketed comparator products or placebo.

Timeline

Start
2011-10
Primary completion
2012-04
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bravelle Unknown 150 iu —
Subject FSH-GEX™ Protein / enzyme biologic 75 iu Subcutaneous
Subject FSH-GEX™ Protein / enzyme biologic 150 iu Subcutaneous
Comparator Gonal-f Protein / enzyme biologic 150 iu —

Indications